Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
429 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Kaiser Permanente-Baldwin Park
Baldwin Park, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Kaiser Permanente Dublin
Dublin, California, United States
- Kaiser Permanente-Fontana
Fontana, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Kaiser Permanente-Fresno
Fresno, California, United States
- Kaiser Permanente South Bay
Harbor City, California, United States
- City of Hope Seacliff
Huntington Beach, California, United States
- City of Hope at Irvine Lennar
Irvine, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- City of Hope at Long Beach Elm
Long Beach, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Kaiser Permanente West Los Angeles
Los Angeles, California, United States
- Kaiser Permanente-Modesto
Modesto, California, United States
- Memorial Medical Center
Modesto, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Palo Alto Medical Foundation-Gynecologic Oncology
Mountain View, California, United States
- City of Hope Newport Beach
Newport Beach, California, United States
- Kaiser Permanente Oakland-Broadway
Oakland, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Kaiser Permanente-Ontario
Ontario, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Va Palo Alto Health Care System
Palo Alto, California, United States
- Kaiser Permanente - Panorama City
Panorama City, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Jan 2018
- Primary completion
- 31 Dec 2025
- Completion
- 21 Jan 2027
- Last update posted
- 8 Jul 2026
- Registered enrollment
- 73
- Registry id
- NCT03269669
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.